12 results on '"Boldo, Elena"'
Search Results
2. Risk of Childhood Asthma Prevalence Attributable to Residential Proximity to Major Roads in Montreal, Canada
- Author
-
Price, Karine, Plante, Celine, Goudreau, Sophie, Boldo, Elena Isabel Pascua, Perron, Stéphane, and Smargiassi, Audrey
- Published
- 2012
3. HEALTH IMPACT ASSESSMENT OF ENVIRONMENTAL TOBACCO SMOKE IN EUROPEAN CHILDREN: SUDDEN INFANT DEATH SYNDROME AND ASTHMA EPISODES
- Author
-
Robson, Mark Gregory, Boldo, Elena, Medina, Sylvia, Öberg, Mattias, Puklová, Vladimíra, Mekel, Odile, Patja, Kristiina, Dalbokova, Dafina, Krzyzanowski, Michal, and Posada, Manuel
- Published
- 2010
4. Atlas of Cancer Mortality in Portugal and Spain (2003–2012)
- Author
-
Fernandez-Navarro, Pablo L, Roquette, Rita, Nuñez, Olivier, de Sousa-Uva, Mafalda, Garcia-Perez, Javier, Lopez-Abente, Gonzalo, Nunes, Baltazar, Gonzalez-Sanchez, Mario, Dinis, José, Carmona-Alferez, Rocio, Rocha Rodrigues, Jéssica, Aragones, Nuria, Bento, María José, Castello Pastor, Adela, Rego, Raúl, Lope Carvajal, Virginia, Henrique, Rui, Boldo, Elena, Pais, Ana, Fernandez de Larrea, Nerea, Bastos, Joana, Ramis, Rebeca, Carrito, Branca, Pastor-Barriuso, Roberto, Miranda, Ana, Perez-Gomez, Beatriz, Forjaz, Gonçalo, Matias Dias, Carlos, Pollan-Santamaria, Marina, Instituto de Salud Carlos III. Centro Nacional de Epidemiología (CNE). Departamento de Enfermedades Crónicas. Unidad de Epidemiología del Cáncer y Ambiental, Instituto de Salud Carlos III. Centro de Investigación Biomédica en Red - CIBERESP (Epidemiología y Salud Pública), Instituto Nacional de Saúde Doutor Ricardo Jorge. Departamento de Epidemiologia. Unidade de Investigação Epidemiológica, and Instituto de Salud Carlos III
- Subjects
Enviromental health ,Neoplasias da Próstata ,Lung Neoplasms ,Esophageal Neoplasms ,Epidemiology ,España ,Breast Neoplasms ,Cáncer de Laringe ,Cáncer de Páncreas ,Stomach Neoplasms ,Saúde Ambiental ,Neoplasias Gástricas ,Epidemiología ,Leukaemia ,Leucemia ,Cáncer de Estómago ,Mortality ,Neoplasias Laríngeas ,Epidemiologia ,Laryngeal Neoplasms ,Cancer ,Neoplasias Colorretais ,Cáncer de Colón ,Portugal ,Cáncer de Próstata ,Prostatic Neoplasms ,Cáncer de Pecho ,Cáncer ,Neoplasias de la Vejiga Urinaria ,Pancreatic Neoplasms ,Urinary Bladder Neoplasms ,Spain ,Neoplasias Pulmonares ,Mortalidad ,Mortalidade ,Cáncer de Esófago ,Cáncer de Pulmón ,Câncer ,Cáncer de Vejiga ,Colorectal Neoplasms ,Neoplasias da Mama ,Neoplasias Esofágicas ,Neoplasias Pancreáticas ,Salud ambiental - Abstract
El 'Atlas of Cancer Mortality in Portugal and Spain 2003–2012', muestra la distribución espacial de la mortalidad municipal por distintos tipos cáncer para el periodo 2003-2012. Ha sido desarrollado por la Unidad de Epidemiología del Cáncer y Ambiental del Centro Nacional de Epidemiología del ISCIII, que forma parte del CIBERESP, y por el Departamento de Epidemiología del Instituto Nacional De Saúde Doutor Ricardo Jorge de Portugal. El estudio de la distribución geográfica del riesgo de fallecer por cáncer es una de las herramientas que se usan en epidemiología para generar hipótesis sobre la posible implicación de factores ambientales en el origen de los tumores. This project is partially supported by research grant from the Spanish Health Research Fund (FIS) of the National Institute of Health Carlos III (ISCIII), Spain (Project PI17CIII/00040: “Spatial distribution of municipal cancer mortality in Spain (SICAMSA)” (“Distribución Espacial de la Mortalidad municipal por CÁncer en ESpaña (DEMOCAES)”). Introduction. Methods. Results: Oesophagus (ICD-10 C15) Stomach (ICD-10 C16) Colorectal (ICD-10 C18–C21) Pancreas (ICD-10 C25) Larynx (ICD-10 C32) Lung (ICD-10 C33–C34) Female Breast (ICD-10 C50) Prostate (ICD-10 C61) Bladder (ICD-10 C67) Leukaemia (ICD-10 C91–C95) References. Annexes: Annex I and Annex II No
- Published
- 2021
5. Evidence-based public health policy and practice: Reducing ambient levels of fine particulates could substantially improve health: a mortality impact assessment for 26 European cities
- Author
-
Ballester, Ferran, Medina, Sylvia, Boldo, Elena, Goodman, Pat, Neuberger, Manfred, Iñiguez, Carmen, and Künzli, Nino
- Published
- 2008
6. Population-based multicase-control study in common tumors in Spain (MCC-Spain): Rationale and study design = Estudio multicaso-control de base poblacional de tumores comunes en España (MCC-Spain): razón y diseño del estudio
- Author
-
Castaño-Vinyals, Gemma, Aragonés, Nuria, Pérez-Gómez, Beatriz, Martín, Vicente, Llorca, Javier, Moreno, Victor, Altzibar, Jone-Miren, Ardanaz, Eva, Sanjosé Llongueras, Silvia de, Jiménez Moleón, José Juan, García Tardón, Adonina, Alguacil, Juan, Peiró Pérez, Rosana, Marcos-Gragera, Rafael, Navarro, Carmen, Pollán, Marina, Kogevinas, Manolis, Alonso, Maria Teresa, Amiano, Pilar, Arias, Cristina, Azpiri, Mikel, Benavente, Yolanda, Boldo, Elena, Bueno, Aurora, Bustamante, Mariona, Caballero, Francisco Javier, Campo Güerri, Elias, Cantón, Rafael, Capelo, Rocío, Carmona García, Maria Carme, Casabonne, Delphine, Chirlaque, María Dolores, Cirac, Judith, Clofent, Juan, Colado, Enrique, Costas, Laura, Crous, Marta, Campo, Rosa del, Díaz Santos, Marian, Dierssen Sotos, Trinidad, Ederra, María, Espinosa, Ana, Fernández Cabrera, Marieta, Fernández Somoano, Ana, Fernández-Villa, Tania, García García-Esquinas, Esther, García Martín, Paloma, Gómez Acebo, Inés, González Puga, Cristina, Gracia Lavedan, Esther, Guevara, Marcela, Guinó, Elisabet, Huerta, José María, Lope, Virginia, López-Abente Ortega, Gonzalo, López-Otín, Carlos, Martínez Argüelles, Begoña, Merino Salas, Sergio, Mirón Pozo, Benito, Molina de la Torre, Antonio José, Moreno, Eduardo, Moreno Iribas, Conchi, Olea, Nicolás, Osca-Gelis, Gemma, Paré, Laia, Porta, Miquel, Puig, Montse, Rivas del Fresno, Manuel, Robles, Claudia, Rodríguez Suarez, Marta María, Romero, Beatriz, Sáez Castillo, Ana Isabel, Sala i Serra, Maria, Salas Trejo, Dolores, Santaballa, Ana, Santibáñez, Miguel, Sierra, Ángeles, Souto, Ana, Villanueva, Cristina M., Carrasco, Estela, Sabaté, Yasmin, Persavento, Cecília, García, Mireia, Carrasco, Glòria, Expósito, Ainara, Andreu, Montse, Bessa, Xavier, Piracés, Mercè, Lorente, José Antonio, Tusquets, Ignasi, Collet, Inma, Bory, Felip, Pera, Manuel, Abella, Eugènia, Garcia, Francesc, Salar, Antonio, Piñol, Marta, Fernández-Llamazares Rodríguez, Jaume, Viciano Martín, Marta, and Garsot, Elisenda
- Subjects
Epidemiology ,Epidemiologia ,Càncer ,Cancer - Abstract
MCC-Spain study group: Maria Teresa Alonso, Pilar Amiano, Cristina Arias, Mikel Azpiri, Yolanda Benavente, Elena Boldo, Aurora Bueno, Mariona Bustamante, Francisco Javier Caballero, Elías Campo, Rafael Cantón, Rocío Capelo, Carme Carmona, Delphine Casabonne, María Dolores Chirlaque, Judith Cirac, Juan Clofent, Enrique Colado, Laura Costas, Marta Crous, Rosa del Campo, Marian Díaz Santos, Trinidad Dierssen-Sotos, María Ederra, Ana Espinosa, Marieta Fernández Cabrera, Ana Fernández Somoano, Fernández-Villa, Tania, Esther García García-Esquinas, Paloma García Martín, Inés Gómez-Acebo, Cristina González Puga, Esther Gràcia, Marcela Guevara Eslava, Elisabet Guinó, José María Huerta, Virginia Lope, Gonzalo López-Abente, Carlos Lopez-Otín, Begona˜ Martinez Argüelles, Sergio Merino Salas, Benito Mirón Pozo, Antonio José Molina de la Torre, Eduardo Moreno, Concepción Moreno Iribas, Nicolás Olea, Gemma Osca Gelis, Laia Paré, Miquel Porta, Montse Puig, Manuel Rivas del Fresno, Claudia Robles, Marta María Rodríguez Suarez, Beatriz Romero, Ana Isabel Sáez Castillo, Maria Sala Serra, Dolores Salas Trejo, Ana Santaballa, Miguel Santibánez, ˜ Ángeles Sierra, Ana Souto, Cristina M Villanueva We present the protocol of a large population-based case-control study of 5 common tumorsin Spain (MCC-Spain) that evaluates environmental exposures and genetic factors.Methods: Between 2008-2013, 10,183 persons aged 20-85 years were enrolled in 23 hospitals and pri-mary care centres in 12 Spanish provinces including 1,115 cases of a new diagnosis of prostate cancer,1,750 of breast cancer, 2,171 of colorectal cancer, 492 of gastro-oesophageal cancer, 554 cases of chroniclymphocytic leukaemia (CLL) and 4,101 population-based controls matched by frequency to cases by age,sex and region of residence. Participation rates ranged from 57% (stomach cancer) to 87% (CLL cases) andfrom 30% to 77% in controls. Participants completed a face-to-face computerized interview on sociode-mographic factors, environmental exposures, occupation, medication, lifestyle, and personal and familymedical history. In addition, participants completed a self-administered food-frequency questionnaireand telephone interviews. Blood samples were collected from 76% of participants while saliva sampleswere collected in CLL cases and participants refusing blood extractions. Clinical information was recordedfor cases and paraffin blocks and/or fresh tumor samples are available in most collaborating hospitals.Genotyping was done through an exome array enriched with genetic markers in specific pathways. Mul-tiple analyses are planned to assess the association of environmental, personal and genetic risk factorsfor each tumor and to identify pleiotropic effects.Discussion: This study, conducted within the Spanish Consortium for Biomedical Research in Epidemiol-ogy & Public Health (CIBERESP), is a unique initiative to evaluate etiological factors for common cancersand will promote cancer research and prevention in Spain
- Published
- 2020
7. Colorectal cancer mortality and industrial pollution in Spain
- Author
-
López-Abente Gonzalo, García-Pérez Javier, Fernández-Navarro Pablo, Boldo Elena, and Ramis Rebeca
- Subjects
Epidemiology ,Colorectal neoplasms ,Industrial pollution ,Environmental pollution/prevention and control ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Records kept as a result of the implementation of Integrated Pollution Prevention and Control (IPPC) and the European Pollutant Release and Transfer Register (E-PRTR) constitute a public inventory of industries, created by the European Commission, which is a valuable resource for monitoring industrial pollution. Our objective is to ascertain whether there might be excess colorectal cancer mortality among populations residing in the vicinity of Spanish industrial installations that are governed by the IPPC Directive and E-PRTR Regulation and report their emissions to air. Methods An ecological study was designed to examine colorectal cancer mortality at a municipal level (8098 Spanish towns), over the period 1997–2006. We conducted an exploratory "near vs. far" analysis to estimate the relative risks (RR) of towns situated at a distance of less than 2 km from industrial installations. The analysis was repeated for each of the 24 industrial groups. RR and their 95% credible/confidence intervals (95%CI) were estimated on the basis of Poisson regression models, using two types of modelling: a) the conditional autoregressive Bayesian model proposed by Besag, York and Mollié, with explanatory variables; and b) a mixed regression model. Integrated nested Laplace approximations were used as a Bayesian inference tool. Results Statistically significant RRs were detected in the vicinity of mining industry (RR 1.258; 95%CI 1.082 - 1.463), paper and wood production (RR 1.071; 95%CI 1.007 – 1.140), food and beverage sector (RR 1.069; 95%CI 1.029 - 1.111), metal production and processing installations (RR 1.065; 95% CI 1.011 – 1.123) and ceramics (RR 1.050 ; 95%CI 1.004 – 1.099). Conclusions Given the exploratory nature of this study, it would seem advisable to check in other countries or with other designs, if the proximity of industries that emit pollutants into the air could be an added risk factor for colorectal cancer mortality. Nevertheless, some of the differences between men and women observed in the analyses of the industrial groups suggest that there may be a component of occupational exposure, little-studied in the case of cancers of the digestive system.
- Published
- 2012
- Full Text
- View/download PDF
8. Meat intake, methods and degrees of cooking and breast cancer risk in the MCC-Spain study.
- Author
-
Boldo, Elena, Castelló, Adela, Aragonés, Nuria, Amiano, Pilar, Pérez-Gómez, Beatriz, Castaño-Vinyals, Gemma, Martín, Vicente, Guevara, Marcela, Urtiaga, Carmen, Dierssen-Sotos, Trinidad, Fernández-Tardón, Guillermo, Moreno, Victor, Solans, Marta, Peiró, Rosanna, Capelo, Rocio, Gómez-Acebo, Inés, Castilla, Jesús, Molina, Antonio José, Castells, Xavier, and Altzibar, Jone M.
- Subjects
- *
BREAST cancer risk factors , *PUBLIC health , *EPIDEMIOLOGY , *REGRESSION analysis , *WOMEN'S health , *BREAST tumors , *COOKING , *DIET , *MEAT , *QUESTIONNAIRES , *PERIMENOPAUSE , *CASE-control method - Abstract
Objective: To analyse the relationship of the risk of breast cancer (BC) to meat intake, preference regarding degree of cooking ('doneness') and cooking methods, using data from a population-based case-control study (MCC-Spain).Study Design: 1006 Histologically confirmed incident BC cases and 1370 controls were recruited in 10 Spanish provinces. Participants were 23-85 years old. They answered an epidemiological survey and a food frequency questionnaire. BC risk was assessed overall, by menopausal status and by pathological subtypes, using logistic and multinomial regression mixed models adjusted for known confounding factors and including province as a random effects term.Main Outcome Measures: Breast cancer and pathological subtype.Results: High total intake of meat (ORQ4-Q1 (95% IC) = 1.39 (1.03-1.88)) was associated with increased BC risk among post-menopausal women. Similar results were found for processed/cured meat (ORQ4-Q1 (95% IC) = 1.47 (1.10-1.97)), and this association was particularly strong for triple-negative tumours (ER-, PR- and HER2-) (ORQ4-Q1 (95% IC) = 2.52 (1.15-5.49)). Intakes of well-done (ORwell-donevsrare (95% CI) = 1.62 (1.15-2.30)) and stewed (OR (95% CI) = 1.49 (1.20-1.84)) red meat were associated with increased BC risk, with a high risk observed for HR+ tumours (ER+/PR+ and HER2-). Pan-fried/bread-coated fried white meat, but not doneness preference, was associated with an increased BC risk for all women (OR (95% CI) = 1.38 (1.14-1.65)), with a stronger association for pre-menopausal women (OR (95% CI) = 1.78 (1.29-2.46)).Conclusion: The risk of developing BC could be reduced by moderating the consumption of well-done or stewed red meat, pan-fried/bread-coated fried white meat and, especially, processed/cured meat. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
9. Mediterranean Dietary Pattern is Associated with Low Risk of Aggressive Prostate Cancer: MCC-Spain Study.
- Author
-
Castelló, Adela, Boldo, Elena, Amiano, Pilar, Castaño-Vinyals, Gemma, Aragonés, Nuria, Gómez-Acebo, Inés, Peiró, Rosana, Jimenez-Moleón, Jose Juan, Alguacil, Juan, Tardón, Adonina, Cecchini, Lluís, Lope, Virginia, Dierssen-Sotos, Trinidad, Mengual, Lourdes, Kogevinas, Manolis, Pollán, Marina, and Pérez-Gómez, Beatriz
- Subjects
PROSTATE cancer prevention ,MEDITERRANEAN diet ,EPIDEMIOLOGY ,DIETARY supplements ,NUTRITIONAL value ,DISEASE incidence - Abstract
Purpose We explored the association of the previously described Western, prudent and Mediterranean dietary patterns with prostate cancer risk by tumor aggressiveness and extension. Materials and Methods MCC-Spain (Multicase-Control Study on Common Tumors in Spain) is a population based, multicase-control study that was done in 7 Spanish provinces between September 2008 and December 2013. It collected anthropometric, epidemiological and dietary information on 754 histologically confirmed incident cases of prostate cancer and 1,277 controls 38 to 85 years old. Three previously identified dietary patterns, including Western, prudent and Mediterranean, were reconstructed using MCC-Spain data. The association of each pattern with prostate cancer risk was assessed by logistic regression models with random, province specific intercepts. Risk according to tumor aggressiveness (Gleason score 6 vs greater than 6) and extension (cT1-cT2a vs cT2b-cT4) was evaluated by multinomial regression models. Results High adherence to a Mediterranean dietary pattern rich not only in fruits and vegetables but also in fish, legumes and olive oil was specifically associated with a lower risk of Gleason score greater than 6 prostate cancer (quartile 3 vs 1 relative RR 0.66, 95% CI 0.46–0.96 and quartile 4 vs 1 relative RR 0.68, 95% CI 0.46–1.01, p-trend = 0.023) or with higher clinical stage (cT2b-T4 quartile 4 vs 1 relative RR 0.49, 95% CI 0.25–0.96, p-trend = 0.024). This association was not observed with the prudent pattern, which combines vegetables and fruits with low fat dairy products, whole grains and juices. The Western pattern did not show any association with prostate cancer risk. Conclusions Nutritional recommendations for prostate cancer prevention should consider whole dietary patterns instead of individual foods. We found important differences between the Mediterranean dietary pattern, which was associated with a lower risk of aggressive prostate cancer, and Western and prudent dietary patterns, which had no relationship with prostate cancer risk. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Industrial pollution and pleural cancer mortality in Spain
- Author
-
López-Abente, Gonzalo, Fernández-Navarro, Pablo, Boldo, Elena, Ramis, Rebeca, and García-Pérez, Javier
- Subjects
- *
INDUSTRIAL pollution , *CANCER-related mortality , *PLEURA cancer , *BIOINDICATORS , *ASBESTOS & health , *MESOTHELIOMA ,SEX differences (Biology) - Abstract
Abstract: Pleural cancer mortality is an acknowledged indicator of exposure to asbestos and mesothelioma mortality but in 15%–20% of cases no exposure can be recalled. In the past, asbestos was used in many industries and it is still found in many installations. Our objective was to ascertain whether there might be excess pleural cancer mortality among populations residing in the vicinity of Spanish industrial installations that are governed by the Integrated Pollution Prevention and Control (IPPC) Directive and the European Pollutant Release and Transfer Register Regulation and report their emissions to air. An ecological study was designed to examine pleural cancer mortality at a municipal level (8098 Spanish towns) over the period 1997–2006, during which 2146 deaths were registered. We conducted an exploratory “near vs. far” analysis to estimate the relative risks (RRs) of towns situated at a distance of <2km from installations. This analysis was repeated for each of the 24 industrial groups. RR and their 95% credible intervals (95% CIs) were estimated on the basis of a Poisson conditional autoregressive Bayesian model with explanatory variables. Integrated nested Laplace approximations were used as a Bayesian inference tool. Analysis showed statistically significant RRs in both sexes in the vicinity of 7 of the 24 industrial groups studied (RR, 95% CI), namely, biocide facilities (2.595, 1.459–4.621), ship-building (2.321, 1.379–3.918), glass and mineral fibre production (1.667, 1.041–2.665), non-hazardous waste treatment (1.737, 1.077–2.799), galvanising (1.637, 1.139–2.347), organic chemical plants (1.386, 1.075–1.782) and the food and beverage sector (1.255, 1.006–1.562). In the proximity of sources pertaining to the biocide, organic chemical and galvanising sectors, the risk was seen to be rising among men and women, a finding that could indicate airborne environmental exposure. These results support that residing in the vicinity of IPPC-registered industries that release pollutants to the air constitutes a risk factor for pleural cancer. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
11. Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain
- Author
-
Nerea Fernández de Larrea-Baz, Angelika Michel, Beatriz Romero, Beatriz Pérez-Gómez, Victor Moreno, Vicente Martín, Trinidad Dierssen-Sotos, José J. Jiménez-Moleón, Jesús Castilla, Adonina Tardón, Irune Ruiz, Rosana Peiró, Antonio Tejada, María D. Chirlaque, Julia A. Butt, Rocío Olmedo-Requena, Inés Gómez-Acebo, Pedro Linares, Elena Boldo, Antoni Castells, Michael Pawlita, Gemma Castaño-Vinyals, Manolis Kogevinas, Silvia de Sanjosé, Marina Pollán, Rosa del Campo, Tim Waterboer, Nuria Aragonés, [Fernandez de Larrea-Baz, Nerea] Inst Salud Carlos III, Area Natl Ctr Epidemiol, Environm & Canc Epidemiol Area, Madrid, Spain, [Perez-Gomez, Beatriz] Inst Salud Carlos III, Area Natl Ctr Epidemiol, Environm & Canc Epidemiol Area, Madrid, Spain, [Aragones, Nuria] Inst Salud Carlos III, Area Natl Ctr Epidemiol, Environm & Canc Epidemiol Area, Madrid, Spain, [Fernandez de Larrea-Baz, Nerea] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain, [Dierssen-Sotos, Trinidad] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain, [Jimenez-Moleon, Jose J.] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain, [Castilla, Jesus] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain, [Tardon, Adonina] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain, [Peiro, Rosana] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain, [Chirlaque, Maria D.] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain, [Olmedo-Requena, Rocio] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain, [Gomez-Acebo, Ines] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain, [Boldo, Elena] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain, [Castano-Vinyals, Gemma] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain, [Kogevinas, Manolis] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain, [de Sanjose, Silvia] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain, [Pollan, Marina] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain, [Aragones, Nuria] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain, [Michel, Angelika] German Canc Res Ctr, Div Mol Diagnost Oncogen Infect Infect Inflammat, Heidelberg, Germany, [Butt, Julia A.] German Canc Res Ctr, Div Mol Diagnost Oncogen Infect Infect Inflammat, Heidelberg, Germany, [Pawlita, Michael] German Canc Res Ctr, Div Mol Diagnost Oncogen Infect Infect Inflammat, Heidelberg, Germany, [Waterboer, Tim] German Canc Res Ctr, Div Mol Diagnost Oncogen Infect Infect Inflammat, Heidelberg, Germany, [Perez-Gomez, Beatriz] Ramon & Cajal Univ Hosp IRYCIS, Dept Microbiol, Madrid, Spain, [del Campo, Rosa] Ramon & Cajal Univ Hosp IRYCIS, Dept Microbiol, Madrid, Spain, [Perez-Gomez, Beatriz] IIS Puerta Hierro, Puerta Hierro Hlth Res Inst, Canc Epidemiol Res Grp Oncol & Hematol Area, Madrid, Spain, [Boldo, Elena] IIS Puerta Hierro, Puerta Hierro Hlth Res Inst, Canc Epidemiol Res Grp Oncol & Hematol Area, Madrid, Spain, [Pollan, Marina] IIS Puerta Hierro, Puerta Hierro Hlth Res Inst, Canc Epidemiol Res Grp Oncol & Hematol Area, Madrid, Spain, [Moreno, Victor] Hosp Llobregat, Catalan Inst Oncol, Canc Prevent & Control Program, Barcelona, Spain, [Moreno, Victor] Univ Barcelona, Fac Med, Dept Clin Sci, Barcelona, Spain, [Moreno, Victor] Hosp Llobregat, Bellvitge Biomed Res Inst IDIBELL, Colorectal Canc Grp, Barcelona, Spain, [Martin, Vicente] Univ Leon, Res Grp Gene Environm & Hlth Interact, Leon, Spain, [Martin, Vicente] Univ Leon, Fac Hlth Sci, Dept Biomed Sci, Area Prevent Med & Publ Hlth, Leon, Spain, [Dierssen-Sotos, Trinidad] Univ Cantabria IDIVAL, Sch Med, Div Epidemiol & Computat Biol, Santander, Spain, [Jimenez-Moleon, Jose J.] Inst Invest Biosanitaria Granada, Granada Hlth Res Inst ibs GRANADA, Granada, Spain, [Olmedo-Requena, Rocio] Inst Invest Biosanitaria Granada, Granada Hlth Res Inst ibs GRANADA, Granada, Spain, [Jimenez-Moleon, Jose J.] Univ Granada, Dept Prevent Med & Publ Hlth, Granada, Spain, [Olmedo-Requena, Rocio] Univ Granada, Dept Prevent Med & Publ Hlth, Granada, Spain, [Castilla, Jesus] Inst Salud Publ Navarra, IdiSNA Navarra Inst Hlth Res, Pamplona, Spain, [Tardon, Adonina] Univ Oviedo, Oncol Inst, Dept Med, Mol Epidemiol Canc Unit, Oviedo, Spain, [Ruiz, Irune] Donostia Univ Hosp, Dept Pathol, Donostia San Sebastian, Spain, [Peiro, Rosana] Fdn Promot Hlth & Biomed Res Valencia Reg FISABIO, Fdn La Fomento Invest Sanitaria & Biomed Comunita, Valencia, Spain, [Tejada, Antonio] Huelva Univ, Hosp Complex, Dept Gen Surg, Coloproctol Unit, Huelva, Spain, [Chirlaque, Maria D.] IMIB Arrixaca, Reg Hlth Council, Dept Epidemiol, Murcia, Spain, [Chirlaque, Maria D.] Univ Murcia, Dept Hlth & Social Sci, Murcia, Spain, [Linares, Pedro] Univ Leon, Dept Gastroenterol & Hepatol Complejo Asis, Leon, Spain, [Castells, Antoni] Hosp Clin Barcelona, Gastroenterol Dept, Barcelona, Spain, [Castells, Antoni] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain, [Castells, Antoni] CIBER Enfermed Hepat & Digestivas CIBEREHD, CIBER Liver & Digest Dis, Madrid, Spain, [Castells, Antoni] Univ Barcelona, Dept Gastroenterol, Barcelona, Spain, [Castano-Vinyals, Gemma] ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain, [Kogevinas, Manolis] ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain, [Castano-Vinyals, Gemma] Hosp Mar, Med Res Inst IMIM, Barcelona, Spain, [Kogevinas, Manolis] Hosp Mar, Med Res Inst IMIM, Barcelona, Spain, [Castano-Vinyals, Gemma] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain, [Kogevinas, Manolis] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain, [de Sanjose, Silvia] Hosp Llobregat, Catalan Inst Oncol IDIBELL, Canc Epidemiol & Res Program, Barcelona, Spain, [del Campo, Rosa] Red Espanola Invest Patol Infecciosa, Spanish Network Res Infect Dis, Seville, Spain, 'Accion Transversal del Cancer', Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III grants, FEDER funds-a way to build Europe, Fundacion Marques de Valdecilla, Catalan Government DURSI, Junta de Castilla y Leon, Consejeria de Salud of the Junta de Andalucia, Regional Government of the Basque Country, Conselleria de Sanitat of the Generalitat Valenciana, UAM. Departamento de Medicina Preventiva y Salud Pública y Microbiología, Instituto de Salud Carlos III, Fundación Marqués de Valdecilla, Government of Catalonia (España), Junta de Castilla y León (España), Regional Government of Andalusia (España), Generalitat Valenciana (España), Basque Government (España), and Universitat de Barcelona
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Medicina ,Population ,Helicobacteri pilòric ,lcsh:QR1-502 ,Colon neoplasia ,Gastroenterology ,Microbiology ,lcsh:Microbiology ,Serology ,Association ,Colorectal neoplasm ,03 medical and health sciences ,0302 clinical medicine ,Càncer colorectal ,Bacterial infections ,Internal medicine ,Epidemiology ,Non-infectious diseases ,medicine ,CagA ,Risk factor ,education ,Multiplex serology ,Original Research ,education.field_of_study ,biology ,Helicobacter pylori ,business.industry ,Carcinoma ,Case-control study ,Odds ratio ,Metaanalysis ,biology.organism_classification ,Colorectal cancer ,Gastric-cancer ,Chronic infection ,030220 oncology & carcinogenesis ,Immunology ,030211 gastroenterology & hepatology ,business ,Infection - Abstract
Background: Several studies have suggested that Helicobacter pylori (H. pylori) infection is a risk factor for colorectal cancer (CRC), while others have not confirmed this hypothesis. This work aimed to assess the relation of CRC with H. pylori seropositivity and with seropositivity to 16 H. pylori proteins, in the MultiCase-Control study, MCC-Spain. Methods: MCC-Spain is a multicase-control study carried out in Spain from 2008 to 2013. In total, 2,140 histologically-confirmed incident CRC cases and 4,098 population-based controls were recruited. Controls were frequency-matched by sex, age, and province. Epidemiological data were collected through a questionnaire fulfilled by face-to-face interviews and a self-administered food-frequency questionnaire. Seroreactivities against 16 H. pylori proteins were determined in 1,488 cases and 2,495 controls using H. pylori multiplex serology. H. pylori seropositivity was defined as positivity to >= 4 proteins. Multivariable logistic regression mixed models were used to estimate odds ratios (OR) and 95% confidence intervals (CI). Results: H. pylori seropositivity was not associated with increased CRC risk (OR = 0.91; 95% CI: 0.71-1.16). Among H. pylori seropositive subjects, seropositivity to Cag delta showed a lower CRC risk, and risk decreased with increasing number of proteins seropositive. Seropositivity to the most recognized virulence factors, CagA and VacA, was not associated with a higher CRC risk. No statistically significant heterogeneity was identified among tumor sites, although inverse relations were stronger for left colon cancer. An interaction with age and sex was found: H. pylori seropositivity was associated with a lower CRC risk in men younger than 65 and with a higher risk in older women. Conclusions: Our results suggest that neither H. pylori seropositivity, nor seropositivity to the virulence factor CagA are associated with a higher CRC risk. A possible effect modification by age and sex was identified., The study was supported by the "Accion Transversal del Cancer," approved on the Spanish Ministry Council on the 11th October 2007, by the Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), by the Instituto de Salud Carlos III grants, co-funded by FEDER funds-a way to build Europe-(grants PI08/1770, PI09/0773, PI09/1286, PI09/1903, PI09/2078, PI09/1662, PI11/01403, PI14/00613, PI14/01219, and PI15/00069), by the Fundacion Marques de Valdecilla (grant API 10/09), by Catalan Government DURSI (grants 2014SGR647 and 2014SGR756), by the Junta de Castilla y Leon (grant LE22A10-2), by the Consejeria de Salud of the Junta de Andalucia (grant 2009-S0143), by the Regional Government of the Basque Country, and by the Conselleria de Sanitat of the Generalitat Valenciana (grant AP061/10). The funders had no role in the study design, data analysis, data interpretation or writing the manuscript.
- Published
- 2017
12. Industrial pollution and cancer in Spain: An important public health issue.
- Author
-
Fernández-Navarro, Pablo, García-Pérez, Javier, Ramis, Rebeca, Boldo, Elena, and López-Abente, Gonzalo
- Subjects
- *
INDUSTRIAL pollution , *EPIDEMIOLOGY of cancer , *PUBLIC health , *EMISSIONS (Air pollution) , *AIR pollution - Abstract
Cancer can be caused by exposure to air pollution released by industrial facilities. The European Pollutant Release and Transfer Register (E-PRTR) has made it possible to study exposure to industrial pollution. This study seeks to describe the industrial emissions in the vicinity of Spanish towns and their temporal changes, and review our experience studying industrial pollution and cancer. Data on industrial pollutant sources (2007–2010) were obtained from the E-PRTR registries. Population exposure was estimated by the distance from towns to industrial facilities. We calculated the amount of carcinogens emitted into the air in the proximity (<5 km) of towns and show them in municipal maps. We summarized the most relevant results and conclusions reported by ecological E-PRTR-based on studies of cancer mortality and industrial pollution in Spain and the limitations and result interpretations of these types of studies. There are high amounts of carcinogen emissions in the proximity of towns in the southwest, east and north of the country and the total amount of emitted carcinogens is considerable (e.g. 20 Mt of arsenic, 63 Mt of chromium and 9 Mt of cadmium). Although the emissions of some carcinogens in the proximity of certain towns were reduced during the study period, emissions of benzene, dioxins+furans and polychlorinated biphenyls rose. Moreover, the average population of towns lying within a 5 km radius from emission sources of carcinogens included in the International Agency for Research on Cancer list of carcinogens was 9 million persons. On the other hand, the results of the reviewed studies suggest that those Spanish regions exposed to the pollution released by certain types of industrial facilities have around 17% cancer excess mortality when compared with those unexposed. Moreover, excess mortality is focused on digestive and respiratory tract cancers, leukemias, prostate, breast and ovarian cancers. Despite their limitations, ecological studies are a useful tool in environmental epidemiology, not only for proposing etiological hypotheses about the risk of living close to industrial pollutant sources, but also for providing data to account for situations of higher mortality in specific areas. Nevertheless, the reduction of emissions should be a goal, with special relevance given to establishing limits for known carcinogens and other toxic substances in the environs of population centers, as well as industry-specific emission limits. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.